34. 神経線維腫症 Neurofibromatosis Clinical trials / Disease details

臨床試験数 : 133 / 薬物数 : 186 - (DrugBank : 67) / 標的遺伝子数 : 79 - 標的パスウェイ数 : 190

2 trials found

diseases per page:

Showing 1 to 2 of 2 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT04201457 (ClinicalTrials.gov)	January 17, 2020	12/12/2019	A Trial of Dabrafenib, Trametinib and Hydroxychloroquine for Patients With Recurrent LGG or HGG With ...	Phase I/II Trial of Dabrafenib, Trametinib, and Hydroxychloroquine (HCQ) for BRAF V600E-mutant or Tr ...	Low Grade Glioma (LGG) of Brain With BRAF Aberration;High Grade Glioma (HGG) of the Brain With BRAF ...	Drug: Dabrafenib;Drug: Trametinib;Drug: Hydroxychloroquine	Pediatric Brain Tumor Consortium	NULL	Recruiting	1 Year	30 Years	All	75	Phase 1/Phase 2	United States
2	NCT03975829 (ClinicalTrials.gov)	November 4, 2019	30/5/2019	Pediatric Long-Term Follow-up and Rollover Study	An Open Label, Multi-center Roll-over Study to Assess Long-term Effect in Pediatric Patients Treated ...	Diffuse Astrocytoma;Anaplastic Astrocytoma;Astrocytoma;Oligodendroglioma, Childhood;Anaplastic Oligo ...	Drug: dabrafenib;Drug: trametinib	Novartis Pharmaceuticals	NULL	Recruiting	1 Year	N/A	All	250	Phase 4	United States;Belgium;Canada;Czechia;Denmark;France;Germany;Japan;Netherlands;Russian Federation;Spa ...

First Previous1Next Last